(Q34332703)

1 August 2017

1 reference

title

Reconstitution of CD4+ T lymphocytes in HIV-infected individuals following antiretroviral therapy (English)

1 reference

1 August 2017

main subject

anti-retroviral agent

0 references

author name string

Carcelain G

series ordinal

1

1 reference

1 August 2017

Debré P

series ordinal

2

1 reference

1 August 2017

Autran B

series ordinal

3

1 reference

1 August 2017

publication date

1 August 2001

1 reference

Current Opinion in Immunology

1 August 2017

published in

1 reference

1 August 2017

volume

13

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

483-488

1 reference

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

T cell changes after combined nucleoside analogue therapy in HIV primary infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Longer-term immunologic effects and side effects of successful antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Factors influencing T-cell turnover in HIV-1-seropositive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Negative result of cytomegalovirus blood culture with restoration of CD4+ T-cell reactivity to cytomegalovirus after HAART in an HIV-1-infected patient

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Direct evidence for thymic function in adult humans

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

High prevalence of thymic tissue in adults with human immunodeficiency virus-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Early reduction of immune activation in lymphoid tissue following highly active HIV therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Prolonged suppression of human immunodeficiency virus type 1 (HIV-1) viremia in persons with advanced disease results in enhancement of CD4 T cell reactivity to microbial antigens but not to HIV-1 antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Functional T cell reconstitution and human immunodeficiency virus-1-specific cell-mediated immunity during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

HAART in HIV-infected patients: restoration of antigen-specific CD4 T-cell responses in vitro is correlated with CD4 memory T-cell reconstitution, whereas improvement in delayed type hypersensitivity is related to a decrease in viraemia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Relations among CD4 Lymphocyte Count Nadir, Antiretroviral Therapy, and HIV-1 Disease Progression: Results from the EuroSIDA Study

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Maximum suppression of HIV replication leads to the restoration of HIV-specific responses in early HIV disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Dynamics of HIV-specific CD8+ T lymphocytes with changes in viral load.The RESTIM and COMET Study Groups

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Depletion in blood CD11c-positive dendritic cells from HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

Transient mobilization of human immunodeficiency virus (HIV)-specific CD4 T-helper cells fails to control virus rebounds during intermittent antiretroviral therapy in chronic HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

AIDS. Boosting immunity to HIV--can the virus help?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2800%2900245-4

7 January 2021

10.1016/S0952-7915(00)00245-4

Identifiers

DOI

1 reference

1 August 2017

1 reference